(Q29615166)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

30 April 2017

author name string

Heineke J

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

30 April 2017

Molkentin JD

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

August 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

Nature Reviews Molecular Cell Biology

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

30 April 2017

volume

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

30 April 2017

issue

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

30 April 2017

page(s)

589-600

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

Vital epidemiologic clues in heart failure

30 April 2017

cites work

1 reference

Guidelines for the diagnosis and management of heart failure

31 March 2020

1 reference

Long-Term Trends in the Incidence of and Survival with Heart Failure

31 March 2020

1 reference

Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study

31 March 2020

1 reference

Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995

31 March 2020

1 reference

Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations

31 March 2020

1 reference

Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy

31 March 2020

1 reference

Does load-induced ventricular hypertrophy progress to systolic heart failure?

31 March 2020

1 reference

Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death

31 March 2020

1 reference

Control of cardiac growth by histone acetylation/deacetylation

31 March 2020

1 reference

Protein kinase cascades in the regulation of cardiac hypertrophy

31 March 2020

1 reference

Sizing up the heart: development redux in disease.

31 March 2020

1 reference

Seven-transmembrane-spanning receptors and heart function

31 March 2020

1 reference

Calcium-calcineurin signaling in the regulation of cardiac hypertrophy

31 March 2020

1 reference

Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling

31 March 2020

1 reference

Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists

31 March 2020

1 reference

Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure

31 March 2020

1 reference

Transgenic Gαq overexpression induces cardiac contractile failure in mice

31 March 2020

1 reference

A transgenic mouse model of heart failure using inducible Galpha q.

31 March 2020

1 reference

Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways

31 March 2020

1 reference

Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy

31 March 2020

1 reference

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

31 March 2020

1 reference

Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes

31 March 2020

1 reference

RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload

31 March 2020

1 reference

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

31 March 2020

1 reference

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

31 March 2020

1 reference

ErbB2 pathways in heart and neural diseases

31 March 2020

1 reference

ErbB2 is essential in the prevention of dilated cardiomyopathy.

31 March 2020

1 reference

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

31 March 2020

1 reference

Integrins and the myocardium.

31 March 2020

1 reference

Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload

31 March 2020

1 reference

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy

31 March 2020

1 reference

Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc

31 March 2020

1 reference

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

31 March 2020

1 reference

Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure

31 March 2020

1 reference

Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice

31 March 2020

1 reference

Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.

31 March 2020

1 reference

Organization and regulation of mitogen-activated protein kinase signaling pathways

31 March 2020

1 reference

"Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium

31 March 2020

1 reference

Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy

31 March 2020

1 reference

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

31 March 2020

1 reference

Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth

31 March 2020

1 reference

Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

31 March 2020

1 reference

Cytoplasmic signaling pathways that regulate cardiac hypertrophy

31 March 2020

1 reference

Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload

31 March 2020

1 reference

Second nature: biological functions of the Raf-1 "kinase"

31 March 2020

1 reference

Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

31 March 2020

1 reference

The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy

31 March 2020

1 reference

TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.

31 March 2020

1 reference

c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes

31 March 2020

1 reference

Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination

31 March 2020

1 reference

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

31 March 2020

1 reference

c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling

31 March 2020

1 reference

JNK1 is required to preserve cardiac function in the early response to pressure overload

31 March 2020

1 reference

Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo

31 March 2020

1 reference

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling

31 March 2020

1 reference

The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis

31 March 2020

1 reference

p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.

31 March 2020

1 reference

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

31 March 2020

1 reference

Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth

31 March 2020

1 reference

Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress

31 March 2020

1 reference

Calsarcins, a novel family of sarcomeric calcineurin-binding proteins

31 March 2020

1 reference

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex

31 March 2020

1 reference

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

31 March 2020

1 reference

Calcineurin and hypertrophic heart disease: novel insights and remaining questions

31 March 2020

1 reference

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo

31 March 2020

1 reference

Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function

31 March 2020

1 reference

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo

31 March 2020

1 reference

Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo

31 March 2020

1 reference

Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy

31 March 2020

1 reference

Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy

31 March 2020

1 reference

Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice

31 March 2020

1 reference

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy

31 March 2020

1 reference

Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction

31 March 2020

1 reference

The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease

31 March 2020

1 reference

The phosphoinositide 3-kinase pathway

31 March 2020

1 reference

The conserved phosphoinositide 3-kinase pathway determines heart size in mice

31 March 2020

1 reference

Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

31 March 2020

1 reference

Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy

31 March 2020

1 reference

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

31 March 2020

1 reference

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects

31 March 2020

1 reference

Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene

31 March 2020

1 reference

Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice

31 March 2020

1 reference

Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)

31 March 2020

1 reference

Akt1 is required for physiological cardiac growth

31 March 2020

1 reference

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

31 March 2020

1 reference

Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart

31 March 2020

1 reference

Akt/protein kinase B promotes organ growth in transgenic mice

31 March 2020

1 reference

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure

31 March 2020

1 reference

Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes

31 March 2020

1 reference

Nuclear targeting of Akt enhances ventricular function and myocyte contractility

31 March 2020

1 reference

Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy

31 March 2020

1 reference

Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter

31 March 2020

1 reference

Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload

31 March 2020

1 reference

Rapamycin attenuates load-induced cardiac hypertrophy in mice

31 March 2020

1 reference

Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy

31 March 2020

1 reference

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway

31 March 2020

1 reference

Drosophila S6 kinase: a regulator of cell size

31 March 2020

1 reference

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase

31 March 2020

1 reference

Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5

31 March 2020

1 reference

Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling

31 March 2020

1 reference

HDAC4 deacetylase associates with and represses the MEF2 transcription factor

31 March 2020

1 reference

Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases

31 March 2020

1 reference

MEF-2 function is modified by a novel co-repressor, MITR

31 March 2020

1 reference

Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy

31 March 2020

1 reference

Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development

31 March 2020

1 reference

Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding

31 March 2020

1 reference

Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy

31 March 2020

1 reference

Cyclin-dependent kinase-9: an RNAPII kinase at the nexus of cardiac growth and death cascades

31 March 2020

1 reference

Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy.

31 March 2020

1 reference

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo

31 March 2020

1 reference

Calmodulin kinase II inhibition protects against structural heart disease

31 March 2020

1 reference

The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure

31 March 2020

1 reference

Deletion of cytosolic phospholipase A2 promotes striated muscle growth

31 March 2020

1 reference

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

31 March 2020

1 reference

Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.

31 March 2020

1 reference

Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes

31 March 2020

1 reference

Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation

31 March 2020

1 reference

Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases

31 March 2020

1 reference

Endurance training and cardial adaptation (athlete's heart)

31 March 2020

1 reference

Translating the Histone Code

31 March 2020

1 reference

Histone deacetylases (HDACs): characterization of the classical HDAC family

31 March 2020

1 reference

Class II histone deacetylases: versatile regulators

31 March 2020

1 reference

The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression.

31 March 2020

1 reference

The roles of GATA-4, -5 and -6 in vertebrate heart development

31 March 2020

1 reference

Roles of cardiac transcription factors in cardiac hypertrophy

31 March 2020

1 reference

Divergent Signaling Pathways Converge on GATA4 to Regulate Cardiac Hypertrophic Gene Expression

31 March 2020

1 reference

The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.

31 March 2020

1 reference

Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte Viability

31 March 2020

1 reference

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation

31 March 2020

1 reference

Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II.

31 March 2020

1 reference

Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo

31 March 2020

1 reference

NF-kappaB activation is required for the development of cardiac hypertrophy in vivo

31 March 2020

1 reference

Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophy

31 March 2020

1 reference

Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology

31 March 2020

1 reference

Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice

31 March 2020

1 reference

Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor.

31 March 2020

1 reference

Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart

31 March 2020

1 reference

The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

31 March 2020

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1005341571

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16936699

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017